FindTrial
Sign In

Efficacy of Pranlukast on Stepped Down Treatment for well-controlled patients with mild persistent asthma.

Efficacy of Pranlukast on Stepped Down Treatment for well-controlled patients with mild persistent asthma. - Efficacy of Pranlukast on Stepped Down Treatment for well-controlled patients with mild persistent asthma.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001983
Enrollment
60
Registered
2009-05-19
Start date
2009-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

pranlukast, 450mg/day, 6months inhaled corticosteroid, 100mcg/day, 6months

Sponsors

Juntendo University school of medicine, Department of respiratory medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with mild persistent asthma who are well-controlled for at least last 3 months

Exclusion criteria

Exclusion criteria: 1. under 20 years old 2. additional usage of other drugs provided in protocol 3. patients for contraindication 4. patients with malignant tumor 5. pregnant women

Design outcomes

Primary

MeasureTime frame
symptom status of asthma—

Secondary

MeasureTime frame
pulmonary function and status of airway inflammation after 2, 4, 6 months treatment period—

Countries

Japan

Contacts

Public ContactRyo Atsuta

Juntendo University school of medicine Department of respiratory medicine

atsuta@juntendo.ac.jp03-5802-1063

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026